[1. Prendergast B. The changing face of infective endocarditis. Heart. 2006 Jul;92(7):879-85. DOI: 10.1136/ hrt.2005.06725610.1136/hrt.2005.067256186069816216860]Search in Google Scholar
[2. Li SJ, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr;30(4):633-38. DOI: 10.1086/31375310.1086/31375310770721]Search in Google Scholar
[3. Lamas CC, Eykyn SJ. Blood culture negative endocarditis : analysis of 63 cases presenting over 25 years. Heart. 2003 Mar;89(3):258-62. DOI: 10.1136/ heart.89.3.25810.1136/heart.89.3.258176757912591823]Search in Google Scholar
[4. Heiro M, Helenius H, Sundell J, Koskinen P, Engblom E, Nikoskelainen J, et al. Utility of serum C-reactive protein in assessing the outcome of infective endocarditis. Eur Heart J. 2005 Sep;26(18):1873-81. DOI: 10.1093/eurheartj/ehi27710.1093/eurheartj/ehi27715855194]Search in Google Scholar
[5. Gouriet F, Bothelo-Nevers E, Coulibaly B, Raoult D. Evaluation of sedimentation rate, rheumatoid factor, C-reactive protein and tumor necrosis factor for the diagnosis of infective endocarditis. Clin Vaccine Immunol. 2006 Feb;13(2):301. DOI: 10.1128/ CVI.13.2.301.200610.1128/CVI.13.2.301.2006139193816467342]Search in Google Scholar
[6. Simon L, Gauvin F, Amre DV, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004 Jul 15;39(2):206-17. DOI: 10.1086/42199710.1086/42199715307030]Search in Google Scholar
[7. Yu CW, Juan LI, Hsu SC, Chen CK, Wu CW, Lee CC, et al. Role of the procalcitonin in the diagnosis of infective endocarditis: a meta-analysis. Am J Emerg Med. 2013 Jun;31(6):935-41. DOI: 10.1016/j.ajem.2013.03.00810.1016/j.ajem.2013.03.00823601504]Search in Google Scholar
[8. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14- ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J Infect Chemoter. 2011 Dec;17(6):764-69. DOI: 10.1007/s10156-011-0254-x10.1007/s10156-011-0254-x21560033]Search in Google Scholar
[9. Mallet-Coste T, Chenevier-Gobeaux C, Fissore-Magdelein C, Magdelein X, Brod F, Claessens YE. La présepsine (sCD14-ST), nouveau biomarquer de la réponse anti-infectieuse. Ann Fr Med Urgence. 2013 Sept;3(5):305-9. DOI: 10.1007/s13341-013-0347-510.1007/s13341-013-0347-5]Search in Google Scholar
[10. Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14- ST). Clin Chim Acta. 2011 Nov;412(23-24):2157-61. DOI: 10.1016/j.cca.2011.07.02410.1016/j.cca.2011.07.02421839732]Search in Google Scholar
[11. Yaeghashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, et al. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J Infect Chemoter. 2005;11(5):234-38. DOI: 10.1007/s10156-005-0400-410.1007/s10156-005-0400-416258819]Search in Google Scholar
[12. Romualdo LG, Torrella PE, González MV, Sánchez RJ, Hodalgo AH, Freire AO, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Departament. Clin Biochem. 2014 May;47(7):505-8. DOI: 10.1016/j.clinbiochem.2014.02.01110.1016/j.clinbiochem.2014.02.01124560955]Search in Google Scholar
[13. Endo S, Suzuki Y, Takahashi G, Shozushima T, Ishikura H, Murai A, et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemoter. 2012 Dec;18(6):891-97. DOI: 10.1007/ s10156-012-0435-210.1007/s10156-012-0435-222692596]Search in Google Scholar
[14. Werdan K, Dietz S, Löffler B, Niemann S, Bushnaq H, Silber RE, et al. Mechanisms of infective endocarditis: pathogen-host interaction and risk states. Nat Rev Cardiol. 2014;11(1):35-50. DOI: 10.1038/nrcardio.2013.17410.1038/nrcardio.2013.17424247105]Search in Google Scholar
[15. Christiansen JG, Jensen HE, Jensen LK, Koch J, Aalbaek B, Nielsen OL, et al. Systemic inflammatory response and local cytokine expression in porcine models of endocarditis. Acta Pathol Microbiol Immunol Scand. 2014 Apr;122(4):292-300. DOI: 10.1111/apm.1214510.1111/apm.1214523879680]Search in Google Scholar
[16. Habib G, Hoen B, Thornos P, Thuny F, Prendergast, Vilacosta I, et al. Guidelines of the prevention, diagnosis and treatment of infective endocarditis (new version 2009). The task force on the prevention, diagnosis and treatement of infective endocarditis of the European Society of Cardiology. Eur Heart J. 2009;30(19):2369-2413. DOI: 10.1093/eurheartj/ehp28510.1093/eurheartj/ehp28519713420]Search in Google Scholar
[17. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach O, Opal SM, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric subgroup. Surviving Sepsis Campaign: International guidelines for the management of severe sepsis and septic shock:2012. Crit Care Med. 2013 Feb;41(2):580-637. DOI: 10.1097/CCM.0b013e31827e83af10.1097/CCM.0b013e31827e83af23353941]Search in Google Scholar
[18. Giavarina D, Carta M. Determination of reference interval for presepsin, an early marker for sepsis. Biochem Med. 2015;25(1):64-68. DOI: 10.11613/BM.2015.00710.11613/BM.2015.007440131025672468]Search in Google Scholar
[19. Ulla M, Pizzolato E, Lucchiari M, Loiacano M, Soardo F, Forno D, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013 Jul 20;17(4):R168. DOI: 10.1186/cc1284710.1186/cc12847405676223899120]Search in Google Scholar
[20. Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values? Clin Chim Acta. 2014 Jan 1;427:34-36. DOI: 10.1016/j.cca.2013.09.01910.1016/j.cca.2013.09.01924076253]Search in Google Scholar
[21. Behnes M, Bertsch T, Lepiorz D, Lang S, Trinkmann F, Brueckmann M, et al. Diagnostic and prognostic utility of soluble CD14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit Care. 2014;18(5):507. DOI: 10.1186/ s13054-014-0507-z10.1186/s13054-014-0507-z417428325190134]Search in Google Scholar
[22. Liu B, Yin Q, Chen YX, Zhao YZ, Li CS. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community- acquired pneumonia in an emergency department. Resp Med. 2014 Aug;108(8):1204-13. DOI: 10.1016/j. rmed.2014.05.005]Search in Google Scholar
[23. Zou Q, Wen W, Zhang X. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5(1):16-19. DOI: 10.5847/wjem.j.issn.1920-8642.2014.01.00210.5847/wjem.j.issn.1920-8642.2014.01.002412985725215141]Search in Google Scholar
[24. Murdoch DR, Corey GR, Hoen B, Miro J, Fowler VG, Bayer AS, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st Century. Arch Intern Med. 2009 Mar 9; 169(5):463-473. DOI: 10.1001/archinternmed.2008.60310.1001/archinternmed.2008.603362565119273776]Search in Google Scholar
[25. Tariq M, Alam M, Munir G, Khan MA, Smego RA Jr. Infective endocarditis: a five - year experience at a tertiary care hospital in Pakistan. Int J Infect Dis. 2004 May;8(3):163-70. DOI: 10.1016/j.ijid.2004.02.00110.1016/j.ijid.2004.02.00115109591]Search in Google Scholar
[26. Kapla JM, Wrong HR. Biomarker discovery and the development in pediatric critical care medicine. Pediatr Crit Care Med. 2011;12(2):165-73. DOI: 10.1097/PCC.0b013e3181e28876 10.1097/PCC.0b013e3181e28876292446220473243]Search in Google Scholar